Key facts: Sanofi plans to invest a minimum of $20 billion in the U.S. by 2030, focusing on enhancing its manufacturing and research capabilities.
阅读少于1分钟
- Sanofi plans to invest a minimum of $20 billion in the U.S. by 2030, focusing on enhancing its manufacturing and research capabilities.1
- Berenberg analysts noted Sanofi's adjusted profitability improved due to an accounting change, raising the 2024 operating margin estimate to 33%. Shares fell by 1.4% after the news.2
- The FDA approved updated COVID-19 vaccines for those over 65, including Sanofi's vaccine, alongside options from Pfizer and Moderna.3